| Record ID | marc_records_scriblio_net/part15.dat:153413083:1006 |
| Source | Scriblio |
| Download Link | /show-records/marc_records_scriblio_net/part15.dat:153413083:1006?format=raw |
LEADER: 01006cam 2200277 a 4500
001 2005271858
003 DLC
005 20050308080251.0
008 050222s2002 ctua s 000 0 eng
010 $a 2005271858
020 $a1569658439 (pbk.)
040 $aDLC$cDLC
050 00 $aHD9666.5$b.R68 2002
245 00 $aPlant-derived drugs :$bproducts, technologies, and applications /$cAndrew McWilliams, project analyst.
260 $aNorwalk, CT :$bBusiness Communications Co.,$cc2002.
300 $axxi, 127, [7] leaves :$bill. ;$c28 cm.
440 0 $aBusiness opportunity report ;$vB-121N
500 $a"February 2003"--T.p. verso.
500 $aRev. ed. of: Plant-derived drugs / Philip Rotheim. 1998.
650 0 $aNonprescription drug industry$xTechnological innovations.
650 0 $aAlternative medicine.
650 0 $aHerbs$xTherapeutic use.
650 0 $aMarket surveys.
700 1 $aMcWilliams, Andrew.
700 1 $aRotheim, Philip.$tPlant-derived drugs.
710 2 $aBusiness Communications Co.